Search
for

    Sort by

    Research

    990-1000 / 1000+ results
      The Polycystic Ovary Syndrome

      research The polycystic ovary syndrome

      August 2008 in “Obstetrics & gynecology science”
      Polycystic Ovary Syndrome (PCOS) is a complex disorder with both immediate and long-term health effects, including menstrual issues, infertility, and increased risk of diabetes and heart disease.
      Slow Progress in Prostate Cancer

      research Slow progress in prostate cancer

      February 2007 in “BJUI”
      Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.
      New Proprietary Brands: Gabapentin

      research NEW PROPRIETARY BRANDS: Gabapentin

      October 2004 in “Australian Prescriber”
      Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.
      New Drugs: Iobenguane Sulfate

      research New drugs: Iobenguane sulfate

      October 2004 in “Australian Prescriber”
      Lifestyle changes are more effective than metformin in reducing type 2 diabetes risk in women with PCOS.
      New Proprietary Brands: Cephalexin

      research NEW PROPRIETARY BRANDS: Cephalexin

      October 2004 in “Australian Prescriber”
      Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.
      New Drugs: Agalsidase Beta

      research New drugs: Agalsidase beta

      October 2004 in “Australian Prescriber”
      Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

      research Reply by the authors

      September 2004 in “Urology”
      Dutasteride may help prevent prostate cancer, but more research is needed.